Jonathan Harry Schatz

24PUBLICATIONS
97CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity.

|Nov 07, 2025
Racial and clinical determinants of response in 2304 large B-cell lymphomas treated with CD19 CAR T in clinical trials.

Soon Jye Kho, Sheila Diamond, Penelope Lafeuille

|Aug 02, 2025
Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline.

Toral Shastri, Asaad Trabolsi, Artavazd Arumov

|Jul 31, 2025
Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy.

Paola Manara, Austin D Newsam, Venu Venkatarame Gowda Saralamma

|May 22, 2025
Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Benjamin Diamond, Dhanvantri Chahar, Michael D Jain

|Mar 17, 2025
RHOA Loss of Function Impairs the IFNγ Response and Promotes CD19 Antigen Escape to Drive CAR-T Resistance in Diffuse Large B-cell Lymphoma.

Austin D Newsam, Bachisio Ziccheddu, Venu Venkatarame Gowda Saralamma

Pageof 4

Frequent Collaborators

5 joint publications

Francesco Maura

4 joint publications

Artavazd Arumov

4 joint publications

Ola Landgren

4 joint publications

Asaad Trabolsi